Table of Contents
1. Overview and Scope
1.1. Research goal & scope
1.2. Research assumptions
1.3. Research methodology
1.3.1. Primary data sources
1.3.2. Secondary data sources
1.4. Key take-aways
1.5. Stakeholders
2. Executive Summary
2.1. Market definition
2.2. Market segmentation
3. Blood Testing Market Insights
3.1. Blood Testing – Industry snapshot
3.2. Blood Testing - Ecosystem analysis
3.3. Blood Testing Market Dynamics
3.3.1. Blood Testing – Market Forces
3.3.1.1. Blood Testing Market Driver Analysis
3.3.1.2. Blood Testing Market Restraint/Challenges analysis
3.3.1.3. Blood Testing Market Opportunity Analysis
3.3.2. Industry analysis - Porter's five force
3.3.2.1. Bargaining power of supplier
3.3.2.2. Bargaining power of buyer
3.3.2.3. Threat of substitute
3.3.2.4. Threat of new entrant
3.3.2.5. Degree of competition
3.3.3. Blood Testing Market PEST Analysis, 2017
3.3.4. Blood Testing Market Value Chain Analysis
3.3.5. Blood Testing Industry Trends
3.3.6. Competitive Ranking Analysis
4. Blood Testing Market Size and Forecast, 2017-2026 by Test Type
4.1. Key Findings
4.2. Glucose testing
4.3. Lipid Profile
4.4. Liver function tests
4.5. Prostate specific antigen
4.6. Hormones
4.7. Blood Urea Nitrogen
4.8. High-sensitivity C-reactive protein
4.9. Thyroid stimulating hormone
4.10. Serum nicotine/cotinine
4.11. Others
5. Blood Testing Market Size and Forecast, 2017-2026 by Product Type
5.1. Key Findings
5.2. Instruments
5.3. Software and Services
5.4. Reagents & Testing Kits
6. Blood Testing Market Size and Forecast, 2017-2026 by End-Users
6.1. Key Findings
6.2. Laboratory
6.3. Hospitals
6.4. Point of Care (POC) Testing
6.5. Blood banks
7. Blood Testing Market Size and Forecast, 2017-2026 by Region
7.1. Key Findings
7.2. North America
7.2.1. U.S.
7.2.2. Canada
7.3. Europe
7.3.1. Germany
7.3.2. UK
7.3.3. Russia
7.3.4. Rest of Europe
7.4. Asia-Pacific
7.4.1. China
7.4.2. Japan
7.4.3. Rest of Asia-Pacific
7.5. Latin America
7.5.1. Brazil
7.5.2. Mexico
7.6. Middle East & Africa
8. Company Profiles
8.1. Abbott
8.1.1. Overview
8.1.2. Financials
8.1.3. Product Benchmarking
8.1.4. Recent Developments
8.2. Alere, Inc.
8.2.1. Overview
8.2.2. Financials
8.2.3. Product Benchmarking
8.2.4. Recent Developments
8.3. Becton Dickinson and Company
8.3.1. Overview
8.3.2. Financials
8.3.3. Product Benchmarking
8.3.4. Recent Developments
8.4. Bio-Rad Laboratories
8.4.1. Overview
8.4.2. Financials
8.4.3. Product Benchmarking
8.4.4. Recent Developments
8.5. Beckman Coulter
8.5.1. Overview
8.5.2. Financials
8.5.3. Product Benchmarking
8.5.4. Recent Developments
8.6. bioMérieux SA
8.6.1. Overview
8.6.2. Financials
8.6.3. Product Benchmarking
8.6.4. Recent Developments
8.7. Biomerica Inc.
8.7.1. Overview
8.7.2. Financials
8.7.3. Product Benchmarking
8.7.4. Recent Developments
8.8. Bruker Corporation
8.8.1. Overview
8.8.2. Financials
8.8.3. Product Benchmarking
8.8.4. Recent Developments
8.9. Cepheid
8.9.1. Overview
8.9.2. Financials
8.9.3. Product Benchmarking
8.9.4. Recent Developments
8.10. Nanosphere Inc.
8.10.1. Overview
8.10.2. Financials
8.10.3. Product Benchmarking
8.10.4. Recent Developments
8.11. Nipro Diagnostics
8.11.1. Overview
8.11.2. Financials
8.11.3. Product Benchmarking
8.11.4. Recent Developments
8.12. Roche Diagnostics
8.12.1. Overview
8.12.2. Financials
8.12.3. Product Benchmarking
8.12.4. Recent Developments
8.13. Siemens AG
8.13.1. Overview
8.13.2. Financials
8.13.3. Product Benchmarking
8.13.4. Recent Developments
8.14. Thermo Fisher Scientific Inc.
8.14.1. Overview
8.14.2. Financials
8.14.3. Product Benchmarking
8.14.4. Recent Developments
8.15. Trinity Biotech PLC
8.15.1. Overview
8.15.2. Financials
8.15.3. Product Benchmarking
8.15.4. Recent Developments